{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:21:18Z","timestamp":1762809678755,"version":"3.28.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00210-024-03244-y","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:08:15Z","timestamp":1719338895000},"page":"9811-9821","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ziprasidone population pharmacokinetics and co-medication effects in Chinese patients"],"prefix":"10.1007","volume":"397","author":[{"given":"Shuang","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"2","key":"3244_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.yic.0000188213.46667.f1","volume":"21","author":"W Aichhorn","year":"2006","unstructured":"Aichhorn W, Marksteiner J, Walch T et al (2006) Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations. Int Clin Psychopharmacol 21(2):81\u201385","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"3244_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/tpj.2014.67","volume":"15","author":"M Apell\u00e1niz-Ruiz","year":"2015","unstructured":"Apell\u00e1niz-Ruiz M, Inglada-P\u00e9rez L, Naranjo ME et al (2015) High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme. Pharmacogenomics J 15(3):288\u2013292","journal-title":"Pharmacogenomics J"},{"key":"3244_CR3","doi-asserted-by":"crossref","unstructured":"Beunk L, Nijenhuis M, Soree B et al (2023) Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. Eur J Hum Genet 32(3):278\u2013285","DOI":"10.1038\/s41431-023-01347-3"},{"issue":"5","key":"3244_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40262-018-0719-5","volume":"58","author":"S Bins","year":"2019","unstructured":"Bins S, Huitema ADR, Laven P et al (2019) Impact of CYP3A4*22 on pazopanib pharmacokinetics in cancer patients. Clin Pharmacokinet 58(5):651\u2013658","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"3244_CR5","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1124\/dmd.106.014456","volume":"35","author":"L Cerveny","year":"2007","unstructured":"Cerveny L, Svecova L, Anzenbacherova E et al (2007) Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 35(7):1032\u20131041","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"3244_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1177\/0269215508101743","volume":"23","author":"ZH Chen","year":"2009","unstructured":"Chen ZH, Wang GH, Wang XP et al (2009) Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial. Clin Rehabil 23(11):963\u2013972","journal-title":"Clin Rehabil"},{"issue":"4","key":"3244_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/03602532.2021.1917598","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen J, Liu J, Huang Y et al (2021) Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug Metab Rev 53(4):491\u2013507","journal-title":"Drug Metab Rev"},{"issue":"6","key":"3244_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1389200023337054","volume":"3","author":"PB Danielson","year":"2002","unstructured":"Danielson PB (2002) The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 3(6):561\u2013597","journal-title":"Curr Drug Metab"},{"key":"3244_CR9","doi-asserted-by":"crossref","unstructured":"De Leon J (2015) The effects of antiepileptic inducer in neuropsychopharmacology, a neglected issue. Part I: a summary of the current state for clinicians. Rev Psiquiatr Salud Ment 8(2):97\u2013115","DOI":"10.1016\/j.rpsmen.2015.04.006"},{"issue":"1","key":"3244_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/pgs.12.187","volume":"14","author":"L Elens","year":"2013","unstructured":"Elens L, van Gelder T, Hesselink DA et al (2013) CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy. Pharmacogenomics 14(1):47\u201362","journal-title":"Pharmacogenomics"},{"issue":"8","key":"3244_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2174\/1389200220666190806141825","volume":"20","author":"S El-Shair","year":"2019","unstructured":"El-Shair S, Al Shhab M, Zayed K et al (2019) Association between CYP3A4 and CYP3A5 genotypes and cyclosporine\u2019s blood levels and doses among Jordanian kidney transplanted patients. Curr Drug Metab 20(8):682\u2013694","journal-title":"Curr Drug Metab"},{"key":"3244_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115000","volume":"396","author":"I Hannachi","year":"2020","unstructured":"Hannachi I, Ben Fredj N, Chadli Z et al (2020) Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant. Toxicol Appl Pharmacol 396:115000","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1\u201302","key":"3244_CR13","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1\u201302):9\u201362","journal-title":"Pharmacopsychiatry"},{"key":"3244_CR14","unstructured":"https:\/\/www.pharmvar.org\/gene\/CYP3A4. Accessed November 30,2023."},{"issue":"4","key":"3244_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2217\/pgs-2016-0179","volume":"18","author":"GX Hu","year":"2017","unstructured":"Hu GX, Dai DP, Wang H et al (2017) Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population. Pharmacogenomics 18(4):369\u2013379","journal-title":"Pharmacogenomics"},{"issue":"3","key":"3244_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"YQ Huang","year":"2019","unstructured":"Huang YQ, Wang Y, Wang H et al (2019) Prevalence of mental disorders in China: a cross-sectional epidemiological stydy. Lancet Psychiatry 6(3):211\u2013224","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"3244_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3736\/jcim20110506","volume":"9","author":"CC Hung","year":"2011","unstructured":"Hung CC, Fu PK, Wang HY et al (2011) Treatment effects of traditional Chinese medicines Suoquan Pill and Wuling Powder on clozapine-induced hypersalivation in patients with schizophrenia: study protocol of a randomized, placebo-controlled trial. Zhong Xi Yi Jie He Xue Bao 9(5):495\u2013502","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"3","key":"3244_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4306\/pi.2017.14.3.360","volume":"14","author":"D Lv","year":"2017","unstructured":"Lv D, Zhao M, Chen L et al (2017) An inter-ethnic comparison study of ziprasidone plasma levels, dosage and clinical response in patients with schizophrenia. Psychiatry Investig 14(3):360\u2013367","journal-title":"Psychiatry Investig"},{"issue":"6","key":"3244_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/JCP.0000000000000607","volume":"36","author":"SC Man","year":"2016","unstructured":"Man SC, Li XB, Wang HH et al (2016) Peony-glycyrrhiza decoction for antipsychotic-related hyperprolactinemia in women with schizophrenia: a randomized controlled trial. J Clin Psychopharmacol 36(6):572\u2013579","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"3244_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/10837450902891485","volume":"41","author":"JM Nicolas","year":"2009","unstructured":"Nicolas JM, Espie P, Molimard M (2009) Gender and interindividual variability in pharmacokinetics. Drug Metab Rev 41(3):408\u2013421","journal-title":"Drug Metab Rev"},{"key":"3244_CR21","doi-asserted-by":"crossref","unstructured":"Olagunju A, Schipani A, Siccardi M et al (2014) CYP3A4*22 (c.522\u2013191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults. Pharmacogenet Genomics 24(9):459\u2013463","DOI":"10.1097\/FPC.0000000000000073"},{"issue":"12","key":"3244_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1176\/appi.ajp.2015.14101251","volume":"172","author":"GI Papakostas","year":"2015","unstructured":"Papakostas GI, Fava M, Baer L et al (2015) Ziprasidone augmentation of escitalopram for major depressive disorder: efficacy results from a randomized, double-blind, placebo-controlled study. Am J Psychiatry 172(12):1251\u20131258","journal-title":"Am J Psychiatry"},{"issue":"3","key":"3244_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jmoldx.2018.01.011","volume":"20","author":"VM Pratt","year":"2018","unstructured":"Pratt VM, Del Tredici AL, Hachad H et al (2018) Recommendations for clinical CYP2C19 genotyping allele selection: a report of the association for molecular pathology. J Mol Diagn 20(3):269\u2013276","journal-title":"J Mol Diagn"},{"issue":"5","key":"3244_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jmoldx.2019.04.003","volume":"21","author":"VM Pratt","year":"2019","unstructured":"Pratt VM, Cavallari LH, Del Tredici AL et al (2019) Recommendations for clinical CYP2C9 genotyping allele selection: a joint recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn 21(5):746\u2013755","journal-title":"J Mol Diagn"},{"issue":"7","key":"3244_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jmoldx.2020.04.204","volume":"22","author":"VM Pratt","year":"2020","unstructured":"Pratt VM, Cavallari LH, Del Tredici AL et al (2020) Recommendations for clinical warfarin genotyping allele selection: a report of the Association for Molecular Pathology and the College of American Pathologists. J Mol Diagn 22(7):847\u2013859","journal-title":"J Mol Diagn"},{"issue":"9","key":"3244_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jmoldx.2021.05.013","volume":"23","author":"VM Pratt","year":"2021","unstructured":"Pratt VM, Cavallari LH, Del Tredici AL et al (2021) Recommendations for clinical CYP2D6 genotyping allele selection: a joint consensus recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy. J Mol Diagn 23(9):1047\u20131064","journal-title":"J Mol Diagn"},{"issue":"9","key":"3244_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jmoldx.2023.06.008","volume":"25","author":"VM Pratt","year":"2023","unstructured":"Pratt VM, Cavallari LH, Fulmer ML et al (2023) CYP3A4 and CYP3A5 genotyping recommendations: a joint consensus recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. J Mol Diagn 25(9):619\u2013629","journal-title":"J Mol Diagn"},{"issue":"6","key":"3244_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/01.chi.0000215347.93902.3e","volume":"45","author":"FR Sallee","year":"2006","unstructured":"Sallee FR, Miceli JJ, Tensfeldt T et al (2006) Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents. J Am Acad Child Adolesc Psychiatry 45(6):720\u2013728","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"3244_CR29","first-page":"70","volume":"23","author":"TM Si","year":"2017","unstructured":"Si TM, Liu TB, Zhang ZH et al (2017) Pharmacology of benzodiazepines. Chinese J Drug Abuse Prev Treat 23(2):70\u201374","journal-title":"Chinese J Drug Abuse Prev Treat"},{"key":"3244_CR30","doi-asserted-by":"crossref","unstructured":"van der Weide K, van der Weide J (2014) The influence of the CYP3A4*22 polymorphism on serum concentration of quetiapine in psychiatric patients. J Clin Psychopharmacol 34(2):256-260","DOI":"10.1097\/JCP.0000000000000070"},{"key":"3244_CR31","doi-asserted-by":"crossref","unstructured":"Wang D, Guo Y, Wrighton SA et al (2011) Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J 11(4):274\u2013286","DOI":"10.1038\/tpj.2010.28"},{"issue":"5","key":"3244_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","volume":"52","author":"X Wen","year":"2001","unstructured":"Wen X, Wang JS, Kivist\u00f6 KT et al (2001) In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Br J Clin Pharmacol 52(5):547\u2013553","journal-title":"Br J Clin Pharmacol"},{"issue":"41","key":"3244_CR33","first-page":"687","volume":"108","author":"K Wenzel-Seifert","year":"2011","unstructured":"Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int 108(41):687\u2013693","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"3244_CR34","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1177\/0091270010387604","volume":"51","author":"AM Wessels","year":"2011","unstructured":"Wessels AM, Bies RR, Pollock BG et al (2011) Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. J Clin Pharmacol 51(11):1587\u20131591","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"3244_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.clpt.2005.11.015","volume":"79","author":"A Westlind-Johnsson","year":"2006","unstructured":"Westlind-Johnsson A, Hermann R, Huennemeyer A et al (2006) Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity. Clin Pharmacol Ther 79(4):339\u2013349","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"3244_CR36","doi-asserted-by":"publisher","first-page":"57S","DOI":"10.1046\/j.1365-2125.2000.00154.x","volume":"49","author":"KD Wilner","year":"2000","unstructured":"Wilner KD, Hansen RA, Folger CJ et al (2000) The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid. Br J Clin Pharmacol 49(Suppl 1):57S-60S","journal-title":"Br J Clin Pharmacol"},{"key":"3244_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.113098","volume":"402","author":"K Yoshida","year":"2021","unstructured":"Yoshida K, Takeuchi H (2021) Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia. Behav Brain Res 402:113098","journal-title":"Behav Brain Res"},{"issue":"9\u201310","key":"3244_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","volume":"17","author":"F Zhang","year":"2012","unstructured":"Zhang F, Xue J, Shao J et al (2012) Compilation of 222 drugs\u2019 plasma protein binding data and guidance for study designs. Drug Discov Today 17(9\u201310):475\u2013485","journal-title":"Drug Discov Today"},{"key":"3244_CR39","volume-title":"Chinese Guidelines for the prevention and treatment of schizophrenia","author":"JP Zhao","year":"2015","unstructured":"Zhao JP, Shi SX (2015) Chinese Guidelines for the prevention and treatment of schizophrenia, 2nd edn. Chinese Medical Multimedia Press, Beijing","edition":"2"},{"key":"3244_CR40","doi-asserted-by":"publisher","first-page":"1160452","DOI":"10.3389\/fpsyt.2023.1160452","volume":"14","author":"H Zhu","year":"2023","unstructured":"Zhu H, Ning Y, Zheng S et al (2023) Effect of Shi-Zhen-An-Shen herbal formula granule in the treatment of young people at ultra-high risk for psychosis: a pilot study. Front Psychiatry 14:1160452","journal-title":"Front Psychiatry"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03244-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T07:04:52Z","timestamp":1732172692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03244-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3244"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03244-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the Declaration of Helsinki. This research was carried out at the Beijing Anding Hospital, Capital University, with the official endorsement of the hospital\u2019s institutional ethics committee [Ethical Approval No. (2022) Research No. 154].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The data of this retrospective study are anonymous, and the requirement for informed consent was therefore waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}